In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific SYNERGY Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in this non-inferiority study, which evaluated the one-year rate of target lesion failure (TLF).

ACE is proud to announce that four new Pennsylvania facilities have received accreditation for percutaneous coronary intervention (PCI) services. To receive PCI accreditation, facilities without onsite open-heart surgery must meet the highest standards of PCI care as defined both by ACE and the Commonwealth of Pennsylvania.

The Dual Antiplatelet Therapy (DAPT) study shed light on an issue that has concerned interventional cardiologists who treat patients with drug-eluting stents. Here’s what it means for practicing physicians.

When it comes to hearts, men and women are not created equally. Women who have experienced a heart attack have a higher risk of a subsequent heart attack, or death, compared to men, according to the American Heart Association. To help women live long and well with heart disease, the Cigna Foundation today announced a $100,000 World of Difference grant to New York University College of Nursing (NYUCN) to pilot and test Helping Women Help Themselves to Improve Heart Health.

Continuing dual antiplatelet therapy (DAPT) beyond one year reduced the risk of ischemic events in patients treated with drug-eluting stents, but at the cost of an increased bleeding risk, the DAPT study group reported Nov. 16 at the American Heart Association scientific session in Chicago.

The Affordable Care Act (ACA) mandates that health systems eliminate waste and across the country many have responded with innovative ways to cut billions of dollars in unnecessary costs.

Most operators realize that radiation exposure in the cath lab puts them, plus their staff, at risk of potential cancers in the future. What they may not know is that a number of strategies exist to reduce exposure, and many don’t cost a dime.

Coronary heart disease patients may not understand the risks second-hand smoke have on their health. While 89.7 percent of patients in a study published online Nov. 11 in JAMA: Internal Medicine stated they understood that second-hand tobacco smoke was harmful, only about half realized the relevance to their own lives.